In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
The aggregate gross proceeds to Benitec from the underwritten offering and the concurrent registered direct offering are expected to be approximately $30 million, prior to deducting underwriting ...
Sarepta Therapeutics said on Tuesday a young man has died due to acute liver failure after treatment with its gene therapy for a rare muscular dystrophy.
Scientists at the Allen Institute have made a major breakthrough in research for people living with Dravet Syndrome, which is ...
By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without side effects.
WASHINGTON — Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, sending company shares plummeting more than 25%.
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback